Carbenicillin in patients with cystic fibrosis: clinical pharmacology and therapeutic evaluation

J Pediatr. 1971 Feb;78(2):338-45. doi: 10.1016/s0022-3476(71)80026-4.
No abstract available

MeSH terms

  • Aerosols
  • Anti-Bacterial Agents / pharmacology
  • Aspartate Aminotransferases / blood
  • Child
  • Cystic Fibrosis / drug therapy*
  • Escherichia / drug effects
  • Humans
  • Injections, Intravenous
  • Klebsiella / drug effects
  • Lung Diseases / complications
  • Lung Diseases / drug therapy*
  • Penicillins / therapeutic use*
  • Probenecid / administration & dosage
  • Proteus / drug effects
  • Pseudomonas aeruginosa / drug effects
  • Respiratory Tract Infections / complications
  • Respiratory Tract Infections / drug therapy*
  • Serratia / drug effects
  • Staphylococcus / drug effects

Substances

  • Aerosols
  • Anti-Bacterial Agents
  • Penicillins
  • Aspartate Aminotransferases
  • Probenecid